“Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“,

Original language	American English
State	Published - 2017
Event	BioCanRx Summit - , Canada Duration: 25 Jun 2017 → 2 Jul 2017

Conference

Conference	BioCanRx Summit
Country/Territory	Canada
Period	25/06/17 → 2/07/17

Activities

• 1 Invited talk

Activities per year

• Conference Invited Keynote

  Cohen, C. (Keynote speaker)

  25 Jun 2017 → 2 Jul 2017

  Activity: Talk or presentation › Invited talk

Cite this

• APA
• Author
• BIBTEX
• Harvard
• Standard
• RIS
• Vancouver

Cohen, C. (2017). “Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“,. Paper presented at BioCanRx Summit, Canada.

Cohen, C. / “Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“,. Paper presented at BioCanRx Summit, Canada.

@conference{fe0049384f8441a792c95735c372b0e7,

title = "“Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“,",

author = "C. Cohen",

year = "2017",

language = "American English",

note = "BioCanRx Summit ; Conference date: 25-06-2017 Through 02-07-2017",

}

Cohen, C 2017, '“Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“,', Paper presented at BioCanRx Summit, Canada, 25/06/17 - 2/07/17.

“Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“, / Cohen, C.
2017. Paper presented at BioCanRx Summit, Canada.

Research output: Contribution to conference › Paper › peer-review

TY - CONF

T1 - “Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“,

AU - Cohen, C.

PY - 2017

Y1 - 2017

M3 - Paper

T2 - BioCanRx Summit

Y2 - 25 June 2017 through 2 July 2017

ER -

Cohen C. “Studying and Enhancing T-Cell Mediated Anti-tumor Immunity to Bridge Between Immunotherapy and Personalized Medicine“,. 2017. Paper presented at BioCanRx Summit, Canada.